Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Nordic guidelines 2021 for diagnosis and
Forlagets udgivne version, 1,75 MB, PDF-dokument
BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.
AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Acta Oncologica |
Vol/bind | 60 |
Udgave nummer | 7 |
Sider (fra-til) | 931-941 |
Antal sider | 11 |
ISSN | 1100-1704 |
DOI | |
Status | Udgivet - 2021 |
Bibliografisk note
Publisher Copyright:
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
ID: 262914043